A 20-year Swedish study examines whether youth hospitalized for self-harm face a higher risk of later psychosis. This research update will help you assess whether these patients are at higher risk before more severe illness develops.

Do SSRIs unmask bipolar disorder in youth? A new Swedish cohort study addresses whether SSRIs trigger mania in children and adolescents with unipolar depression. Learn which risk factors warrant closer monitoring.

Lurasidone was heralded as a game changer when it first gained FDA approval for bipolar depression in 2013. In 2023, this article covers what that means for patients with bipolar disorder and schizophrenia who can now afford its $10–$20/month cost.

What are the best practices for using lithium in older adults? This update outlines dosing strategies, monitoring protocols, and emerging safety data.

Researchers delve into the occurrence of mood switches in bipolar disorder, and consider both manic and depressive episodes.